Detalhe da pesquisa
1.
Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model.
J Antimicrob Chemother
; 78(2): 397-410, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473954
2.
Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model.
J Antimicrob Chemother
; 77(5): 1324-1333, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35211736
3.
Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: the Importance of Heteroresistance for Growth Outcome.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907184
4.
Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic In Vitro Model.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253214
5.
Efficacy of single and multiple oral doses of fosfomycin against Pseudomonas aeruginosa urinary tract infections in a dynamic in vitro bladder infection model.
J Antimicrob Chemother
; 75(7): 1879-1888, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32361749
6.
Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections.
J Antimicrob Chemother
; 75(4): 988-996, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31873748
7.
Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji.
J Glob Antimicrob Resist
; 30: 286-293, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35738385
8.
Epidemiology, antimicrobial resistance and outcomes of Staphylococcus aureus bacteraemia in a tertiary hospital in Fiji: A prospective cohort study.
Lancet Reg Health West Pac
; 22: 100438, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373162
9.
Evaluation of pooled human urine and synthetic alternatives in a dynamic bladder infection in vitro model simulating oral fosfomycin therapy.
J Microbiol Methods
; 171: 105861, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035114
10.
An alternative strategy for combination therapy: Interactions between polymyxin B and non-antibiotics.
Int J Antimicrob Agents
; 53(1): 34-39, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30240838